Clinical Trials on Dental Disease

Total 404366 results

Massachusetts General Hospital
Robert Wood Johnson Foundation

Withdrawn

Toolkit for Experiential Well-beiNg in Dementia (TEND) (TEND)

Dementia | Alzheimer Disease

United States
Celltex Therapeutics Corporation

No longer available

Autologous Human Adipose-Derived Mesenchymal Stem Cells in Alzheimer's Disease

Alzheimer Disease
Yale University
National Institute on Aging (NIA)

Completed

Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease

Alzheimer Disease

United States
Kaiser Permanente
Johns Hopkins University; Duke University; Monash University

Completed

Optimal Medication Management in Alzheimer's Disease and Dementia (Optimize)

Dementia

United States
Emory University
National Institute on Aging (NIA)

Completed

Faith-Based Toolbox for African Americans With Dementia

Dementia | Alzheimer Disease

United States
Cassava Sciences, Inc.
Premier Research Group plc

Active, not recruiting

Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (REFOCUS-ALZ)

Alzheimer Disease

United States, Korea, Republic of, Canada, Puerto Rico
European University Miguel de Cervantes
Asociación de Familiares de Alzheimer de Valladolid

Completed

Influence of Physical Exercise as Adjuvant Treatment in Patients With Alzheimer's Disease

Alzheimer Disease

Spain
NeuroTherapia, Inc.
CRU Early Phase Unit Kistarcsa

Completed

A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07

Alzheimer Disease

United States, Hungary
Cassava Sciences, Inc.
National Institute on Aging (NIA)

Completed

Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients (PTI-125)

Alzheimer Disease

United States, Canada
IRCCS San Raffaele

Completed

PET Study of Acetylcholine Esterase Activity in Alzheimer's Disease

Alzheimer Disease
SciNeuro

Completed

A First Time in Human Study of SNP318 as a Treatment for Neurodegenerative Diseases Including Alzheimer's Disease

Neurodegenerative Diseases | Alzheimer's Disease

Australia
Marc L Gordon, MD
Janssen Scientific Affairs, LLC

Completed

Study of Daratumumab in Patients With Mild to Moderate Alzheimer's Disease (DARZAD)

Alzheimer Disease

United States
TrueBinding, Inc.

Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease

Alzheimer's Disease

United States
Centre Hospitalier Universitaire de Nice

Completed

Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading. (ADAL)

Alzheimer's Disease

France
Massachusetts Institute of Technology

Active, not recruiting

High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease

Alzheimer Disease

United States
Istituto Nazionale di Ricovero e Cura per Anziani
Fondazione Cariverona, Italy

Withdrawn

An Integrated Intervention of Computerized Cognitive Training and Physical Exercise in Virtual Reality for People With Alzheimer's Disease (JDome) (JDome)

Alzheimer Disease

Italy
BrightOutcome
Northwestern University

Completed

SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support (SAGE-LEAF)

Alzheimer Disease

United States
Indiana University
National Institutes of Health (NIH); National Institute on Aging (NIA)

Completed

Caregiver Outcomes of Alzheimer's Disease Screening (COADS)

Alzheimer Disease

United States
Cerecin

Completed

A Phase 1, Two-part, Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Liquid Formulation of Tricaprilin and Matching Placebo in Healthy Subjects

Alzheimer Disease

United States
Cerecin

Terminated

Tricaprilin Liquid Formulation PK Study

Alzheimer Disease

Australia
Mentia DTx
National Institute on Aging (NIA)

Enrolling by invitation

Assessing a Novel Virtual Environment That Assists With Activities of Daily Living

Neurodegenerative Diseases | Dementia | Alzheimer Disease

United States
Genentech, Inc.

Completed

A Study of Semorinemab in Patients With Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Spain, Poland, France
Kaiser Permanente
University of California, San Francisco

Completed

Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT)

Dementia | Alzheimer Disease

United States
Anavex Life Sciences Corp.
Anavex Australia Pty Ltd.; Anavex Germany GmbH

Active, not recruiting

OLE of Phase 2b/3 Study ANAVEX2-73-AD-004 (ATTENTION-AD)

Alzheimer Disease

Australia, Canada, Germany, Netherlands, United Kingdom
Cognition Therapeutics
National Institute on Aging (NIA)

Completed

Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG

Alzheimer Disease

Netherlands
Akdeniz University

Enrolling by invitation

Evaluation of the Structured Caregiver Support Program (SCSP) in Terms of Various Parameters (SCSP)

Alzheimer Disease

Turkey
TrueBinding, Inc.

Available

TB006 Expanded Access (EA) Compassionate Use

Alzheimer Disease
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
Daniela Moga
National Institute on Aging (NIA)

Completed

The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE)

Dementia | Alzheimer's Disease

United States
Oligomerix, Inc

Active, not recruiting

Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants

Alzheimer Disease

United States
University of Pittsburgh
Patient-Centered Outcomes Research Institute

Completed

Optimizing Care for Patients With Dementia

Alzheimer Disease

United States
Suven Life Sciences Limited

Completed

SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study

Alzheimer's Disease

United States
University of California, San Diego
National Institute on Aging (NIA)

Completed

Enhancing Consent for Alzheimer's Research (BWP-AD)

Alzheimer Disease

United States
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

Active, not recruiting

A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)

Alzheimer Disease

China
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.

Active, not recruiting

Long-term Efficacy and Safety Study of GV-971

Alzheimer Disease

China
Photozig, Inc.

Completed

Virtual Patient Behavioral Response Training for Family Caregivers

Alzheimer Disease

United States
Jeff Burns, MD

Completed

Dapagliflozin In Alzheimer's Disease

Alzheimer Disease

United States
Eisai Inc.
Biogen

Active, not recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease

Alzheimer's Disease

United States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
Cerecin

Withdrawn

A Phase III Multi Regional Clinical Trial (MRCT) of Tricaprilin in Mild to Moderately Severe Probable Alzheimer's Disease With Optional Open Label Extension

Alzheimer's Disease
Yale University
National Institute on Aging (NIA)

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics and Receptor Occupancy of BMS-984923

Alzheimer Disease

United States
Elizabeth K Rhodus
National Institute on Aging (NIA)

Completed

Environmental Design for Behavioral Regulation in People With Dementia

Alzheimer Disease

United States
Department of Clinical Research and Innovation

Completed

Comparison for the Patient With Alzheimer Disease the Impact of Three Different Groups of Patient Care (COMPARSE)

Alzheimer Disease

France
Virogenics, Inc.
National Institute on Aging (NIA); Celerion

Completed

Safety, Tolerability and Pharmacokinetics of CMS121, a Drug Candidate for Alzheimer's Disease, in Healthy Subjects (CMS121)

Alzheimer Disease

United States
Hoffmann-La Roche

Completed

A Study of Gantenerumab in Participants With Mild Alzheimer Disease

Alzheimer's Disease

Canada, United States, Spain, Korea, Republic of, Belgium, United Kingdom, Australia, Germany, Portugal, Argentina, Bulgaria, Denmark, Finland, France, Hungary, Italy, Japan, Netherlands, Russian Federation, Sweden, Switzerland, T...
Elisa Konofagou
National Institute on Aging (NIA)

Active, not recruiting

Non-invasive Blood-brain Barrier Opening in Alzheimer's Disease Patients Using Focused Ultrasound

Alzheimer Disease

United States
Indiana University
National Institute on Aging (NIA); Regenstrief Institute, Inc.; Hebrew SeniorLife

Completed

Aligning Patient Preferences: a Role Offering Alzheimer's Patients, Caregivers, and Healthcare Providers Education and Support (APPROACHES)

Dementia | Alzheimer Disease

United States
University Health Network, Toronto

Active, not recruiting

Inhalational Anesthesia and Precipitation of Dementia: is There a Link?

Dementia | Alzheimer's Disease

Canada, Latvia
University of Arkansas

Completed

Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders

Neurodegenerative Diseases | Alzheimer Disease

United States
University of Minnesota
Johns Hopkins University; Brown University; National Institute on Aging (NIA); University...

Completed

Utilizing Senior Companions to Enhance Dementia Care

Dementia | Alzheimer Disease

United States
Azienda Socio Sanitaria Territoriale degli Spedali...

Completed

Modulators of Gamma tACS in Alzheimer's Disease (Mod-GammAD) (Mod-GammAD)

Alzheimer Disease

Italy

Clinical Trials on Dental Disease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations